Methotrexate therapy for psoriasis: revision of guidelines. Methotrexate in psoriasis: revised guidelines. 10Kremer, JM, Alancon, GS, Lightfoot, RW et al, Methotrexate for rheumatoid arthritis: suggested guidelines for monitoring liver toxicity. Monitoring Methotrexate Hepatic Toxicity in Rheumatoid Arthritis: Is It Time to Update the Guidelines? Kremer JM, Alarcon GS, Lightfoot RW Jr, et al. Methotrexate for rheumatoid arthritis: Suggested guidelines for monitoring liver toxicity. Methotrexate in psoriasis: revised guidelines. J Am Acad Dermatol 1988;19:145-56. Methotrexate in psoriasis: Revised guidelines. Newman M, Auerbach R, Feiner H, Holzman RS, Shupack J, Migdal P, et al. The role of liver biopsies in psoriatic patients receiving long-term methotrexate treatment.
Weekly low-dose methotrexate therapy for cutaneous sarcoidosis. Hughes BR, Marks R, Pearse AD, et al. Methotrexate is the most effective systemic agent in psoriasis and has been used by dermatologists for more than 50 years. Various guidelines have been formulated in various countries for prescribing methotrexate, but there is no consensus statement on this issue. Methotrexate in psoriasis: Revised guidelines. J Eur Acad Dermatol Venereol 2011;25: Bishnoi, et al. Its efficacy in the treatment of severe or recalcitrant psoriasis unresponsive to topical therapy earned the drug a new indication in the 1950s (). In a preliminary study, Kozarek et al. Methotrexate in psoriasis: Revised guidelines.
5Roenigk, H.H. Jr., Auerbach, R., Maibach, H.I. et al, Methotrexate guidelines revised.
Weekly Low-dose Methotrexate Therapy For Cutaneous Sarcoidosis